Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Hopes Mount On Sun's 'Game Changer' Psoriasis Asset

Executive Summary

Sun Pharmaceutical Industries Ltd.'s late-stage psoriasis asset has met its primary endpoints in two pivotal studies, setting the stage for increased competition in a crowded and high stakes segment.


Related Content

Sun Underlines 'Competitive Profile' Of Psoriasis Asset In Crowded Market
Sun Builds On Tildrakizumab Hopes With Almirall Pact





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts